Allen & Hanburys Ltd

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 22/12/2011
PIL Seretide 100, 250, 500 Accuhaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 14/09/2011 and displayed until 22/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 07/12/2009 and displayed until 14/09/2011
Reasons for adding or updating:
  • Change to drug interactions
Updated on 14/01/2009 and displayed until 07/12/2009
Reasons for adding or updating:
  • Extra statutory information
Updated on 02/05/2008 and displayed until 14/01/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 24/02/2005 and displayed until 02/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 11/03/2004 and displayed until 24/02/2005
Reasons for adding or updating:
  • Change to side-effects
Updated on 31/07/2003 and displayed until 11/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 21/03/2001 and displayed until 31/07/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   fluticasone propionate
   salmeterol xinafoate